Point72 Asset Management’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.71M Sell
1,047,385
-413,643
-28% -$1.65M 0.01% 1747
2025
Q4
$5.57M Buy
1,461,028
+237,162
+19% +$922K 0.01% 1768
2025
Q3
$3.95M Buy
+1,223,866
New +$4.59M 0.01% 1161
2024
Q4
Sell
-207,100
Closed -$1.36M 2286
2024
Q3
$1.36M Sell
207,100
-396,481
-66% -$3.19M ﹤0.01% 1319
2024
Q2
$4.38M Buy
603,581
+165,181
+38% +$1.27M 0.01% 872
2024
Q1
$3.33M Sell
438,400
-12,000
-3% -$93.5K 0.01% 1104
2023
Q4
$2.05M Sell
450,400
-4,600
-1% -$15.5K 0.01% 1196
2023
Q3
$1.8M Sell
455,000
-384,000
-46% -$1.45M 0.01% 1163
2023
Q2
$2.63M Buy
839,000
+384,000
+84% +$1.57M 0.01% 985
2023
Q1
$2.06M Sell
455,000
-20,000
-4% -$104K 0.01% 970
2022
Q4
$1.96M Hold
475,000
0.01% 937
2022
Q3
$1.52M Buy
+475,000
New +$1.19M 0.01% 987
2022
Q1
Sell
-196,896
Closed -$2.13M 1295
2021
Q4
$2.13M Hold
196,896
0.01% 817
2021
Q3
$2.27M Buy
196,896
+97,736
+99% +$1.17M 0.01% 776
2021
Q2
$974K Buy
99,160
+81,900
+475% +$925K ﹤0.01% 818
2021
Q1
$252K Hold
17,260
﹤0.01% 882
2020
Q4
$370K Hold
17,260
﹤0.01% 855
2020
Q3
$262K Hold
17,260
﹤0.01% 858
2020
Q2
$222K Sell
17,260
-1
-0% -$12 ﹤0.01% 747
2020
Q1
$159K Hold
17,261
﹤0.01% 723
2019
Q4
$230K Buy
+17,261
New +$165K ﹤0.01% 834
2019
Q1
Sell
-43,678
Closed -$2.59M 1135
2018
Q4
$2.59M Buy
43,678
+12,887
+42% +$1.27M 0.01% 677
2018
Q3
$4.32M Sell
30,791
-10,042
-25% -$1.22M 0.02% 632
2018
Q2
$5.01M Buy
+40,833
New +$3.47M 0.02% 604
2015
Q2
Sell
-217
Closed -$103K 794
2015
Q1
$103K Buy
+217
New +$103K ﹤0.01% 662

Other funds holding LRMR